Dr John Campbell PhD, BSc Hons

Institute of Immunology and Immunotherapy
Research Fellow

Contact details

Clinical Immunology
Institute of Immunology and Immunotherapy
College of Medical and Dental Sciences
University of Birmingham
B15 2TT

John is a Research Fellow in the Institute of Immunology and Immunotherapy researching monoclonal gammopathies, including multiple myeloma and monoclonal gammopathy of undetermined significance (MGUS).


  • PhD in Exercise Immunology 2010
  • BSc (Hons) (1st Class) in Sport and Exercise Sciences 2006


John is exploring how exercise and diet affect MGUS disease activity, and MGUS co-morbidities that include immune competence, bone health and renal function. In addition, John maintains an active collaborative research program investigating how physical exercise affects immune function in a range of populations, and has published numerous papers in this area.

He is a co-investigator on the NIHR-funded TEAMM (tackling early morbidity and mortality in myeloma), and is researching how immune-suppression in myeloma impacts upon infection risk, inflammation and refractory myeloma.

He is a co-inventor of University ‘spinout’ company Serascience Ltd - which has recently been acquired by Abingdon Health Ltd - and specialises in novel diagnostic tests for blood cancers, including the first point-of-care (near patient) test for multiple myeloma called Seralite. John has received funding from the MRC, Universitas 21 and internal funds from the University of Birmingham.


Postgraduate supervision

John is interested in supervising doctoral research students in the following areas:

  • Investigation into immune-suppression in multiple myeloma: risk of infections, viral re-activation and myeloma relapse
  • The effects of exercise on immune competence
  • Development of novel immunoassays for the diagnosis and monitoring of plasma cell dyscrasias, including multiple myeloma

If you are interesting in studying any of these subject areas please contact John on the contact details above, or for any general doctoral research enquiries, please email: dr@contacts.bham.ac.uk or call +44 (0)121 414 5005.

For a full list of available Doctoral Research opportunities, please visit our Doctoral Research programme listings.   



  • Multiple myeloma
  • Monoclonal Gammopathy of Undetermined Significance (MGUS)
  • Exercise Immunology
  • Exercise Physiology


Turner JE, Wadley A, Aldred S, Fisher J, Bosch JA and Campbell JP (2016) Intensive Exercise Does Not Preferentially Mobilize Skin-Homing T Cells and NK Cells. Medicine and Science in Sport and Exercise [In press]

Heaney JL, Phillips AC, Drayson MT and Campbell JP (2016) Serum free light chains are reduced in endurance trained older adults: evidence that exercise training may reduce basal inflammation in older adults. Gerontological ageing [In press]

Te Velthuis H, Drayson MT and Campbell JP (2016) Measurement of free light chains with assays based on monoclonal antibodies. Clinical Chemistry and Laboratory Medicine [In press]

Heaney JL, Gleeson M, Phillips AC, Taylor IM, Drayson MT, Goodall M, He CS, Svendsen IS, Killer SC and Campbell JP (2016) Salivary immunoglobulin free light chains: reference ranges and responses to exercise in young and older adults. Exercise Immunology Review 22:28-41

Campbell JP, Eijsvogels TM, Wang Y, Hopman MT and Jacobs JF (2016) Assessment of serum free light chain levels in healthy adults immediately after marathon running. Clinical Chemistry and Laboratory Medicine 54(3):459-65

Brioli A, Giles H, Pawlyn C, Campbell JP, Kaiser MF, Melchor L, Jackson GH, Gregory WM, Owen RG, Davies FE, Cavo M, Drayson MT and Morgan GJ (2014) Serum free immunoglobulin light chain evaluation as a marker of impact from intraclonal heterogeneity on myeloma outcome. Blood 123(22):3414-9

Turner JE, Campbell JP, Edwards KM, Howarth LJ, Pawelec G, Aldred S, Moss P, Drayson MT, Burns VE and Bosch JA (2014) Rudimentary signs of immunosenescence in Cytomegalovirus-seropositive healthy young adults. Age (Dordr) 36(1):287-97

Turner JE, Bennett SJ, Campbell JP, Bosch JA, Aldred S and Griffiths HR (2013) The antioxidant enzyme peroxiredoxin-2 is depleted in lymphocytes seven days after ultra-endurance exercise. Free Radical Research 47(10):821-8